This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (11)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal

One Disease With Many Faces?

Arch Neurol. 2004;61:27-29.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In this issue of ARCHIVES, Guis et al¹ describe a family with autosomal dominant susceptibility to malignant hyperthermia (MH) and muscle histologic characteristics showing multiminicores in the absence of symptoms of weakness or myopathy. There was high concordance in this family among in vitro sensitivity to caffeine and halothane, multiminicores, and novel mutations in the skeletal muscle ryanodine receptor (RYR1) gene. This family illustrates the overlap of these diseases (Table 1) and again demonstrates the power of genetic analysis to either clarify or confuse the boundaries between clinical phenotypes. It also illustrates the potential complexity of this group of diseases in which the "genetic environment" of polymorphisms is critical to the phenotype.

Table appears in full text version. Table. Summary of Central Core Disease, Multiminicore Disease, Malignant Hyperthermia Susceptibility, and an Autosomal-Dominant Multiminicore Family

MH SUSCEPTIBILITY

Malignant hyperthermia susceptibility (MHS) is a genetically heterogeneous susceptibility to life-threatening rigidity, fever, and rhabdomyolysis that is provoked . . . [Full Text of this Article]

CENTRAL CORE DISEASE

MULTIMINICORE DISEASE
Katherine D. Mathews, MD
Departments of Pediatrics and Neurology
2503 JCP
200 Hawkins Dr
University of Iowa
Iowa City, IA 52242
(e-mail: Katherine-Mathews@uiowa.edu)

Steven A. Moore, MD, PhD
Iowa City

RELATED ARTICLE

Multiminicore Disease in a Family Susceptible to Malignant Hyperthermia: Histology, In Vitro Contracture Tests, and Genetic Characterization
Sandrine Guis, Dominique Figarella-Branger, Nicole Monnier, David Bendahan, Geneviève Kozak-Ribbens, Jean-Pierre Mattei, Joël Lunardi, Patrick J. Cozzone, and Jean-François Pellissier
Arch Neurol. 2004;61(1):106-113.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Congenital Myopathies in Israeli Families
Weiss et al.
J Child Neurol 2007;22:732-736.
ABSTRACT  

Central core disease is due to RYR1 mutations in more than 90% of patients
Wu et al.
Brain 2006;129:1470-1480.
ABSTRACT | FULL TEXT  

Malignant Hyperthermia: Update on Susceptibility Testing
Litman and Rosenberg
JAMA 2005;293:2918-2924.
ABSTRACT | FULL TEXT